Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

Sonidegib and vismodegib have different side effects and reporting patterns.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Pexidartinib often causes liver issues and fatigue, especially in women.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Axitinib treatment turned a man's grey hair back to black.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Methotrexate is effective for rheumatoid arthritis but can cause side effects.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Geranyl acetate can protect skin cells from damage and inflammation caused by para-phenylenediamine.

Eclipta alba extract may work as an anticancer agent and help reverse drug resistance.

Apremilast did not work for treating severe alopecia areata.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

JAK inhibitors may help improve symptoms in adults with APECED.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

A woman recovered from hair loss and skin eruptions after stopping a tuberculosis drug and using steroids.

Indinavir, especially with vitamin A, may cause bone changes, but switching to nelfinavir can reduce these effects.

Natural products like propolis are causing more skin allergies, and certain skin treatments and medications have various side effects and risks.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Leflunomide and anthralin may effectively treat severe alopecia areata.